Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-22

Clinical Trial Update: TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.

View source ↗

Summary

A clinical trial update evaluating the effect of TorasEmide on quality of life and clinical parameters in patients with chronic heart failure who are receiving …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TorasEmide
  • eplerenone (eplerenone)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Chronic Heart Failure | Status: UNKNOWN